Related Experiment Video
Updated: Dec 17, 2025
10:31
Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders
Published on: February 9, 2022
4.0K
Transanal Minimally Invasive Surgery (TAMIS) in Qatar: initial experience
A Abutaka1, A Ahmed1, M Abunada1
1Colorectal Surgery Section, Department of Surgery, Hamad General Hospital, P.O Box 3050, Doha, Qatar.
BMC Surgery
|June 21, 2020
Summary
Transanal Minimally Invasive Surgery (TAMIS) is a safe and feasible technique for rectal lesion excision. This approach can help patients avoid radical surgery, offering a valuable option for colorectal services.
Area of Science:
- Colorectal Surgery
- Minimally Invasive Surgery
- Oncology
Background:
- Transanal Minimally Invasive Surgery (TAMIS) combines Transanal Endoscopic Microsurgery (TEM) and laparoscopy.
- It is used for local excision of mid and high rectal lesions, both benign and malignant.
Purpose of the Study:
- To assess the feasibility, safety, and outcomes of TAMIS for rectal lesions.
- To evaluate specimen integrity, operative time, length of stay, and complications.
Main Methods:
- Retrospective review of prospectively collected data from January 2015 to September 2019.
- Seventeen patients underwent TAMIS for benign and malignant rectal lesions at Hamad General Hospital, Doha, Qatar.
Main Results:
- TAMIS was feasible and safe, with an average length of stay of 1.5 days.
- Lesions included adenomas, adenocarcinomas, neuroendocrine tumors, and polyps.
- No specimen fragmentation occurred, except in one case of inflammatory polyp.
Conclusions:
- TAMIS is a viable and safe procedure, even in low-volume centers.
- It offers an alternative to radical surgery for many rectal lesions.
- TAMIS should be integrated into specialized colorectal services.
